OA08878A - Nouveaux (W -ammonio acyloxy méthylène)-5 tétrahydrofuranes et tétrahydrothiophènes, un procédé pour leur préparation et compositions thérapeutiques en contenant. - Google Patents

Nouveaux (W -ammonio acyloxy méthylène)-5 tétrahydrofuranes et tétrahydrothiophènes, un procédé pour leur préparation et compositions thérapeutiques en contenant.

Info

Publication number
OA08878A
OA08878A OA59367A OA59367A OA08878A OA 08878 A OA08878 A OA 08878A OA 59367 A OA59367 A OA 59367A OA 59367 A OA59367 A OA 59367A OA 08878 A OA08878 A OA 08878A
Authority
OA
OAPI
Prior art keywords
tetrahydrothiophenes
tetrahydrofurans
ammonio
preparation
new
Prior art date
Application number
OA59367A
Other languages
English (en)
French (fr)
Inventor
Odfroid Jean-Jacques
Heymans Francois
Braquet Pierre
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of OA08878A publication Critical patent/OA08878A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA59367A 1987-05-29 1988-05-27 Nouveaux (W -ammonio acyloxy méthylène)-5 tétrahydrofuranes et tétrahydrothiophènes, un procédé pour leur préparation et compositions thérapeutiques en contenant. OA08878A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (1)

Publication Number Publication Date
OA08878A true OA08878A (fr) 1989-10-31

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59367A OA08878A (fr) 1987-05-29 1988-05-27 Nouveaux (W -ammonio acyloxy méthylène)-5 tétrahydrofuranes et tétrahydrothiophènes, un procédé pour leur préparation et compositions thérapeutiques en contenant.

Country Status (32)

Country Link
US (1) US5017588A (xx)
JP (1) JPH0631228B2 (xx)
KR (1) KR960005152B1 (xx)
AR (1) AR243885A1 (xx)
AT (1) AT395715B (xx)
AU (1) AU610789B2 (xx)
BE (1) BE1002146A3 (xx)
CA (1) CA1317959C (xx)
CH (1) CH674985A5 (xx)
DE (1) DE3818106A1 (xx)
DK (1) DK167532B1 (xx)
ES (1) ES2009924A6 (xx)
FI (1) FI89353C (xx)
FR (2) FR2615735B1 (xx)
GB (2) GB8712693D0 (xx)
GR (1) GR1000147B (xx)
HK (1) HK101790A (xx)
IE (1) IE61341B1 (xx)
IN (1) IN168799B (xx)
IT (1) IT1219698B (xx)
LU (1) LU87229A1 (xx)
MA (1) MA21289A1 (xx)
MY (1) MY103289A (xx)
NL (1) NL192203C (xx)
NO (1) NO170086C (xx)
NZ (1) NZ224775A (xx)
OA (1) OA08878A (xx)
PT (1) PT87585B (xx)
SE (1) SE466449B (xx)
SG (1) SG93790G (xx)
TN (1) TNSN88049A1 (xx)
ZA (1) ZA883731B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
NL192203B (nl) 1996-11-01
NL8801315A (nl) 1988-12-16
DK291088A (da) 1988-11-30
IE881599L (en) 1988-11-29
GB8812488D0 (en) 1988-06-29
DK167532B1 (da) 1993-11-15
CA1317959C (en) 1993-05-18
FR2615854A1 (fr) 1988-12-02
NO882335L (no) 1988-11-30
SE8801964L (sv) 1988-11-30
AU1672288A (en) 1988-12-01
NO170086C (no) 1992-09-09
GR880100342A (en) 1989-02-23
FR2615854B1 (fr) 1990-12-28
FR2615735B1 (fr) 1991-01-11
SE466449B (sv) 1992-02-17
FR2615735A1 (fr) 1988-12-02
IT8820773A0 (it) 1988-05-27
IN168799B (xx) 1991-06-08
ES2009924A6 (es) 1989-10-16
JPS649988A (en) 1989-01-13
NO882335D0 (no) 1988-05-27
IT1219698B (it) 1990-05-24
US5017588A (en) 1991-05-21
FI89353C (fi) 1993-09-27
GB8712693D0 (en) 1987-07-01
AU610789B2 (en) 1991-05-23
GR1000147B (el) 1991-09-27
ZA883731B (en) 1989-02-22
SG93790G (en) 1991-01-18
GB2205100A (en) 1988-11-30
DK291088D0 (da) 1988-05-27
NL192203C (nl) 1997-03-04
TNSN88049A1 (fr) 1990-07-10
FI882475A0 (fi) 1988-05-26
LU87229A1 (fr) 1988-12-13
SE8801964D0 (sv) 1988-05-26
PT87585A (pt) 1989-05-31
BE1002146A3 (fr) 1990-07-31
KR960005152B1 (ko) 1996-04-22
FI89353B (fi) 1993-06-15
NO170086B (no) 1992-06-01
AR243885A1 (es) 1993-09-30
HK101790A (en) 1990-12-14
IE61341B1 (en) 1994-11-02
KR880013928A (ko) 1988-12-22
ATA140788A (de) 1992-07-15
GB2205100B (en) 1990-08-15
PT87585B (pt) 1992-09-30
DE3818106C2 (xx) 1993-07-01
CH674985A5 (xx) 1990-08-15
JPH0631228B2 (ja) 1994-04-27
AT395715B (de) 1993-02-25
NZ224775A (en) 1990-01-29
MY103289A (en) 1993-05-29
MA21289A1 (fr) 1988-12-31
FI882475A (fi) 1988-11-30
DE3818106A1 (de) 1988-12-15

Similar Documents

Publication Publication Date Title
DZ2128A1 (fr) Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1227A1 (fr) Dérivés de benzopyrane procédé pour leur préparation et médicaments contenant les dits dérivés.
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
FR2610634B1 (fr) Nouveaux polyimide-siloxanes, procedes pour leur preparatio n et articles les contenant
OA08505A (fr) Nouveaux steroides comportant un cycle spirannique en position 17, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
BE880584A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
OA07354A (fr) Nouveaux dérivés de céphalosporine, leur procédé de production et composition pharmaceutique les contenant.
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
LU78113A1 (fr) Nouveaux acides 5-alkoxyimidazo(1,2-a)quinoleine-2-carboxyliques et leurs derives et composition pharmaceutique les contenant ainsi qu'un procede pour leur preparation
OA09442A (fr) Dérivés de la thiéno-triazolo-diazépine, un procédé pour leur préparation et compositions thérapeutiques en contenant.
OA08878A (fr) Nouveaux (W -ammonio acyloxy méthylène)-5 tétrahydrofuranes et tétrahydrothiophènes, un procédé pour leur préparation et compositions thérapeutiques en contenant.
BE885268A (fr) Nouveaux n-propionyl-sarcosine-anilides, procede pour leur preparation et medicaments les contenant
OA08709A (fr) Nouveaux dérivés oxy-5 du tétrahydrofurane, un procédé pour leur préparation et compositions thérapeutiques en contenant.
OA07585A (fr) Nouveaux composés hétérocycliques, leur procédé de préparation et composition pharmaceutique les contenant.
LU79966A1 (fr) Nouveaux 3-indolyl-tertiobutylaminopropanols,leur procede de production et medicament les contenant
OA07390A (fr) Nouveaux dérivés de carbapenem, compositions pharmaceutiques les contenant, composés intermédiaires pour leur préparation, et leurs procédés de production.
OA08740A (fr) Nouveaux méthoxy-5 alcoyl ommonium tétrahydrofuranes et tétrahydrothiophénes, un procédé pour leur préparation et compositions thérapeutiques en contenant.
BE878230A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
OA07341A (fr) Nouveaux oximéthers, procédé pour leur préparation, agents contenant les nouveaux oximéthers et leur application.
BE875247A (fr) Nouveaux antibiotiques du type beta-lactame, leur procede de production et medicament les contenant
BE870576A (fr) Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant
OA09201A (fr) "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant".
FR2625501B1 (fr) Nouveaux derives substitues du styrene, leur procede de preparation et compositions pharmaceutiques les contenant
DZ2250A1 (fr) Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2528422B1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives